Core Viewpoint - The company, Yidu Tech (02158), has been actively repurchasing its shares, demonstrating confidence in its intrinsic value and long-term development [1] Group 1: Share Buyback - On January 28, Yidu Tech announced a share buyback of 204,000 shares at approximately HKD 6 per share, costing around HKD 1.23 million [1] - The company has conducted share buybacks for three consecutive trading days, totaling approximately 709,000 shares repurchased and over HKD 4.2 million spent [1] Group 2: Business Progress - The number of insured individuals under the 2026 Beijing Universal Health Insurance program has surpassed 4.5 million, showcasing the company's operational strength and market recognition [1] - Yidu Tech has been the main operating platform for this project for five consecutive years, contributing to the multi-tiered medical security system in the capital [1] Group 3: International Collaboration and Recognition - The founder and chairman of Yidu Tech, Gong Rujing, attended the 2026 Winter Davos Forum, where a collaboration with Novartis Foundation and the Brunei Ministry of Health was announced for a cardiovascular disease prevention project called CARDIO4Cities [1] - Yidu Tech ranked first in the 2025 Medical Big Data Company Rankings for the seventh consecutive year, reflecting its strong technical foundation, mature product system, and extensive industry experience [1]
医渡科技连续三日回购超420万港元，主运营的北京普惠健康保参保突破450万